Institutions / Atlas Venture Life Science Advisors, LLC
Atlas Venture Life Science Advisors, LLC
CIK 1917529 · Institution · as of Dec 31, 2025
Portfolio value
$865.15M
Positions
8
As of
Dec 31, 2025
Top holdings
Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Kymera Therapeutics, Inc. | $362.58M | 41.9% |
| Dyne Therapeutics, Inc. | $178.59M | 20.6% |
| Sionna Therapeutics, Inc. | $123.24M | 14.2% |
| Disc Medicine, Inc.IRON | $120.22M | 13.9% |
| Day One Biopharmaceuticals, Inc. | $59.77M | 6.9% |
| Korro Bio, Inc. | $9.11M | 1.1% |
| Q32 Bio Inc. | $6.95M | 0.8% |
| Generation Bio, Co. | $4.70M | 0.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.